API China: Rousselot demonstrates pharma solutions

LEADING gelatine and collagen peptides manufacturer, Rousselot (Son, The Netherlands), is showcasing its portfolio of dynamic solutions for the pharmaceutical industry at the year’s API China.

Rousselot will demonstrate the almost unlimited possibilities of its industry-leading Pharmaceutical Gelatine range in supporting producers to overcome technical constraints and deliver innovations across a variety of key pharmaceutical applications.

Visitors to Rousselot’s stand (4AF05) at API China can also learn more about the scientific data supporting the efficacy of the company’s Peptan? collagen peptides, with a particular focus on the range’s healthy aging properties.

Pharmaceutical gelatines

With 120 years’ experience in the manufacture of gelatine, Rousselot is the leading provider of high quality gelatine solutions to the pharmaceutical industry. Developed to meet the specific needs of the pharmaceutical sector, the company’s Pharmaceutical Gelatines adhere to strict quality controls and meet the most stringent regulatory requirements and standards of major pharmaceutical companies.

Setting new standards in the sector, the comprehensive range of gelatines for use in pharmaceutical products include hard and soft capsules, plasma substitutes, tablets and ostomy devices. Combining this unrivalled portfolio breadth with a commitment to innovation and partnership focus, Rousselot works in collaboration with customers to deliver tailored, consistent and proven solutions – whatever the requirements.

Visitors to Rousselot’s stand 4AF05 will be able to see the gelatines in action

Peptan collagen peptides

Containing more than 97% protein (on a dry weight basis), Rousselot’s Peptan collagen peptides are 100 per cent safe, natural and highly bioactive ingredients. Produced using a unique enzymatic hydrolysis process, the peptides offer biofunctional properties not available in any other protein source.

At API China, Rousselot will highlight the multiple proven benefits Peptan collagen peptides offer manufacturers targeting the healthy aging market. A convergent body of scientific evidence has demonstrated Peptan’s ability to promote healthy bones and joints. A new placebo controlled clinical study at Shanghai Sixth People’s Hospital, showed reduced joint pain and improved flexibility after daily intake of Peptan on patients with knee joint problems. Collagen peptides have also been proven to increase bone mass density and strength as well as muscle regeneration. Multiple clinical studies by leading skin institutes incl. COSderma laboratoires, in Bordeaux, France, have shown Peptan’s ability to boost collagen structure and promote younger looking skin, too.

Manufactured exclusively in Rousselot’s state-of-the-art manufacturing facilities in Brazil and France, Peptan collagen peptides are fully traceable and meet the highest international quality and food safety standards. The ingredients can be easily incorporated into a wide range of functional foods and beverages, as well as nutraceutical supplemenNike